Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Cardiac pacing and defibrillation studies, Cardiac Arrhythmias and Treatments, Atrial Fibrillation Management and Outcomes, and Cardiac electrophysiology and arrhythmias.
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial.
An Absorbable Antibacterial Envelope Promotes Development of a Healthy Device Pocket: Results of the TYRX Pocket Health Study.
Correlation between mobile and 12-lead ECG among patients loading with intravenous sotalol: A PEAKS substudy
Sotalol Dosing and Outcomes Among Patients Undergoing Intravenous Loading for Atrial Arrhythmias—A PEAKS Registry Substudy
Preclinical evaluation of a compliant and absorbable cardiac implantable electronic device antibacterial envelope.
Direct Comparison of Two Commercially Available Pulsed Field Ablation Systems for Atrial Fibrillation; Procedure Characteristics and Acute Outcomes.
Sotalol Dosing and Outcomes Among Patients Undergoing Intravenous Loading for Atrial Arrhythmias-A PEAKS Registry Substudy.
Tricuspid valve disease and cardiac implantable electronic devices.
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial
Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation
Defining the blanking period, using continuous ECG monitoring, after cryoballoon pulmonary vein isolation.
Expedited loading with intravenous sotalol is safe and feasible—primary results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.
Performance of Atrial Fibrillation Burden Trends for Stroke Risk Stratification.
Using Atrial Fibrillation Burden Trends and Machine Learning to Predict Near-Term Risk of Cardiovascular Hospitalization.
Tricuspid valve disease and cardiac implantable electronic devices
2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic
Clinical Impact of Standardized TAVR Technique and Care Pathway
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry.
Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
REINFORCING the clinical utility of an antibacterial envelope to prevent infection following a cardiac implantable electronic device implant procedure.
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation